Guardant Health
GH
#1048
Rank
$22.70 B
Marketcap
$169.22
Share price
-3.30%
Change (1 day)
71.07%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Annual Reports

Thumbnail Guardant Health
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report